Icon (ICLR) Stock Forecast & Price Target $185.06 -3.40 (-1.80%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$185.48 +0.42 (+0.23%) As of 10/17/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Icon - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 19 Analyst RatingsSell0Hold8Buy11 Based on 19 Wall Street analysts who have issued ratings for Icon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 8 have given a hold rating, 9 have given a buy rating, and 2 have given a strong buy rating for ICLR. Consensus Price Target $210.6413.82% Upside According to the 19 analysts' twelve-month price targets for Icon, the average price target is $210.64. The highest price target for ICLR is $263.00, while the lowest price target for ICLR is $150.00. The average price target represents a forecasted upside of 13.82% from the current price of $185.06. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for ICLR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Icon and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICLR Analyst Ratings Over TimeTypeCurrent Forecast10/18/24 to 10/18/251 Month Ago9/18/24 to 9/18/253 Months Ago7/20/24 to 7/20/251 Year Ago10/19/23 to 10/18/24Strong Buy2 Strong Buy rating(s)3 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)Buy9 Buy rating(s)9 Buy rating(s)7 Buy rating(s)11 Buy rating(s)Hold8 Hold rating(s)8 Hold rating(s)7 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$210.64$216.67$198.08$346.09Forecasted Upside13.82% Upside20.75% Upside38.00% Upside16.25% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyBuy ICLR Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ICLR Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Icon Stock vs. The CompetitionTypeIconMedical CompaniesS&P 500Consensus Rating Score 2.68 2.33 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside13.82% Upside1,356.34% Upside13.60% UpsideNews Sentiment RatingPositive NewsSee Recent ICLR NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/8/2025Weiss Ratings0 of 5 stars Reiterated RatingHold (C)10/2/2025Barclays3 of 5 starsLuke Sergott Not RatedBoost TargetEqual Weight$180.00 ➝ $190.00-1.20%9/12/2025Cowen1 of 5 stars Reiterated RatingHold9/9/2025Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid WindleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Hold$220.00 ➝ $175.00-1.58%9/3/2025Rothschild RedbSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Strong-Buy9/3/2025Rothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJamie ClarkSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeNeutral ➝ Buy$184.00 ➝ $236.00+32.70%9/2/2025Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingEric ColdwellSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$222.00 ➝ $224.00+27.11%8/21/2025CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick DonnellySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$225.00 ➝ $200.00+10.96%7/25/2025MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAnn HynesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$173.00 ➝ $225.00+22.29%7/25/2025Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJailendra SinghSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$187.00 ➝ $234.00+26.14% Get the Latest News and Ratings for ICLR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Icon and its competitors with MarketBeat's FREE daily newsletter. 7/25/2025UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJohn SourbeerSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$170.00 ➝ $240.00+29.32%7/25/2025Evercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRoss MukenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$170.00 ➝ $240.00+28.37%7/24/2025Baird R WSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Strong-Buy5/2/2025The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingM. SykesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetNeutral$180.00 ➝ $160.00+9.30%4/29/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCasey WoodringSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOverweight ➝ Neutral$265.00 ➝ $150.00+3.45%4/14/2025TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCharles RhyeeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Hold$254.00 ➝ $157.00+9.00%1/15/2025Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingS. DodgeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform$263.00 ➝ $263.00+29.67%1/14/2025William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMax SmockSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform11/19/2024Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOutperform$270.00 ➝ $255.00+34.38%10/14/2024Redburn AtlanticSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJ. ClarkSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingInitiated CoverageNeutral$311.00+5.43%9/18/2024Leerink PartnrsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingM. ChernySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:31 AM ET. Should I Buy Icon Stock? ICLR Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 14, 2025. Please send any questions or comments about these Icon pros and cons to contact@marketbeat.com. Icon Bull Case Here are some ways that investors could benefit from investing in ICON Public Limited: The current stock price is around $183, which may present a buying opportunity for investors looking for growth in the clinical research sector. ICON Public Limited reported earnings per share (EPS) of $3.26 for the latest quarter, exceeding analyst expectations, indicating strong financial performance. The company has a solid market capitalization of approximately $14.35 billion, reflecting its stability and presence in the market. With a return on equity of 10.95%, ICON Public Limited demonstrates effective management and profitability, which can attract investors seeking reliable returns. Analysts have a consensus rating of "Moderate Buy" for the stock, with a target price suggesting potential upside, indicating positive market sentiment. Icon Bear Case Investors should be bearish about investing in ICON Public Limited for these reasons: The company's revenue for the latest quarter was down about 4.8% compared to the same period last year, which may raise concerns about growth sustainability. ICON Public Limited has a price-to-earnings (P/E) ratio of 18.27, which could be considered high, suggesting that the stock may be overvalued relative to its earnings. With a PEG ratio of 2.57, the stock may not be as attractive for growth investors, as this indicates that the stock price is high relative to its expected growth rate. The stock has experienced significant volatility, with a beta of 1.20, meaning it is more volatile than the market, which could pose risks for conservative investors. Recent downgrades from analysts, including a reduction in price targets, may signal caution and uncertainty about the company's future performance. ICLR Forecast - Frequently Asked Questions What is Icon's forecast for 2025? According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Icon is $210.64, with a high forecast of $263.00 and a low forecast of $150.00. Should I buy or sell Icon stock right now? 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Icon in the last twelve months. There are currently 8 hold ratings, 9 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ICLR shares. Does Icon's stock price have much upside? According to analysts, Icon's stock has a predicted upside of 13.82% based on their 12-month stock forecasts. Has Icon been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Icon's stock had 4 upgrades and 1 downgrade by analysts. What analysts cover Icon? Icon has been rated by research analysts at Baird R W, Barclays, Citigroup, Cowen, Evercore ISI, Jefferies Financial Group, Mizuho, Robert W. Baird, Rothschild & Co Redburn, Rothschild Redb, Truist Financial, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Icon more than its competitors? Analysts like Icon more than other "medical" companies. The consensus rating for Icon is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ICLR compares to other companies. Stock Forecasts and Research Tools Related Companies MEDP Stock Forecast CRL Stock Forecast IQV Stock Forecast TMO Stock Forecast TCOM Stock Forecast WCN Stock Forecast RDDT Stock Forecast GRAB Stock Forecast AER Stock Forecast GIB Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:ICLR) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.